Charlottenlund, Denmark

Per Cantor

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Per Cantor

Introduction

Per Cantor is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of medicine, particularly in the treatment of prostate cancer. With a total of 5 patents to his name, Cantor's work has the potential to impact many lives.

Latest Patents

Among his latest patents, Cantor has developed methods for treating prostate cancer using a gonadotrophin-releasing hormone (GnRH) antagonist. This invention provides methods and dosing regimens that safely and effectively treat androgen-dependent prostate cancer without causing a testosterone spike or other side effects commonly associated with GnRH agonist therapy, such as urinary tract infections or cardiovascular issues.

Career Highlights

Throughout his career, Per Cantor has worked with prominent companies in the pharmaceutical industry, including Ferring B.V. and Ferring International Center SA. His experience in these organizations has allowed him to refine his expertise and contribute to innovative medical solutions.

Collaborations

Some of his notable coworkers include Tine Kold Olesen and Bo-Eric Persson. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.

Conclusion

Per Cantor's contributions to the field of prostate cancer treatment exemplify the importance of innovation in medicine. His patents reflect a commitment to improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…